Picton Mahoney Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,521
| Closed | -$2.49M | – | 364 |
|
|
2023
Q4 | $2.49M | Sell |
41,521
-27,556
| -40% | -$1.65M | 0.07% | 177 |
|
|
2023
Q3 | $2.63M | Buy |
69,077
+26,350
| +62% | +$1M | 0.08% | 168 |
|
|
2023
Q2 | $3.89M | Sell |
42,727
-6,048
| -12% | -$551K | 0.17% | 157 |
|
|
2023
Q1 | $3.22M | Buy |
48,775
+15,249
| +45% | +$1.01M | 0.14% | 180 |
|
|
2022
Q4 | $1.73M | Buy |
33,526
+2,676
| +9% | +$138K | 0.08% | 310 |
|
|
2022
Q3 | $2.11M | Buy |
+30,850
| New | +$2.11M | 0.08% | 273 |
|